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Abstract: Two farnesylhydroquinones were isolated from the fruiting bodies of Ganoderma pfeifferi, farnesylhydroquinone (1) and 
the new compound ganomycin K (2), (5S)-3-[(E)-7,8-dihydroxy-4,8-dimethylnon-3-enyl]-5-(2,5-dihydroxyphenyl)-furan-2(5H)-
one. The structures of 1 and 2 were determined on the basis of mass spectrometric and NMR spectroscopic evidence. The 
antibacterial activity of the isolated compounds was neglectable. 
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Introduction 
Ganoderma pfeifferi Bres., a weak parasitic and later  
saprophytic basidiomycete, is a fungus only found in Europe, 
living preferentially on Fagus spp. and some other deciduous 
trees such as Aesculus, Acer, Fraxinus, and Quercus species. 
The fungus can be recognized by its cracked and wrinkled 
resinous layer on the pileus and its sweet scent in winter. Its 
dark brown context makes it distinguishable from older  
specimens of G. lucidum and G. resinaceum.1 
In contrast to G. lucidum and G. applanatum, from which a 
number of biologically and pharmacologically interesting 
triterpenes and polysaccharides have been isolated,2,3 G. 
pfeifferi is one of the phytochemically less well examined  
species of the family Ganodermataceae. Two antibacterial 
farnesylhydroquinones were isolated from G. pfeifferi,4  
followed by the isolation of antiviral triterpenes.5,6 In the 
course of the isolation of larger amounts of the ganomycins A 
and B from G. pfeifferi for subsequent bioactivity studies,  
several other compounds with comparable UV/Vis spectra 
have been observed in chromatograms of various extract  
fractions. Of these compounds, two were characterized  
in more detail. In addition to the known compound  
farnesylhydroquinone (1), we characterized a previously  
unknown compound we named ganomycin K (2). The present 
manuscript describes the isolation and structure elucidation of 
these compounds as well as the biological examination of the 
compounds in regard to their antibacterial activity. 
 
Results and Discussion 
The first compound (1) eluted later than the known  
ganomycins A and B on a C18 HPLC column (tr 1: 9.2 min, tr 
ganomycin A: 7.2 min, tr ganomycin B: 8.5 min). It was  
obtained as a brown oil. GC-EIMS of 1 showed a molecular 
ion peak [M]+ at m/z 314. The 1H NMR spectrum of 1 showed 
close similarities with the spectrum of ganomycin B and  
revealed the presence of the hydroquinone as well as the  
double bonds in the terpene part of the molecule. However, the 
low-field resonance of the methine proton conjugated to the 
carboxylic acid in ganomycin B was missing, but instead a 
methine proton at higher field closer to the other methine  
proton was observed. Furthermore, instead of three methyl 
signals in ganomycin B, four methyl group singulets  
were observed for 1. Thus, 1 has been identified as  
farnesylhydroquinone. Its NMR data are comparable with data 
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published in the literature.7,8 To confirm the identity of 1,  
farnesylhydroquinone has been synthesized. The synthetic 
compound showed the same GC retention time and EI mass 
spectrum. Farnesylhydroquinone (1) has previously been  
isolated from marine organisms such as algae9 and higher 
plants from the families Hydrophyllaceae7 and Piperaceae8, 
and similar compounds have been obtained from sponges10 and 
other plants11. Although a related natural product, 2-methyl-
farnesylhydroquinone, has been found in Penicillium sp.,12  
to the best of our knowledge this is the first report of  
farnesylhydroquinone being isolated from a fungus. However, 
the occurrence of farnesylhydroquinone in Ganoderma 
pfeifferi is not very surprising, as it can be supposed to be the 
biosynthetic precursor of the ganomycins. 
Compound 2 eluted earlier than the known ganomycins on a 
C18 HPLC column (tr 2: 6.4 min) and was obtained as a  
yellow oil. The compound was not stable under the GC-EIMS 
conditions used. From LC-IT-TOFMS, a molecular formula of 
C21H28O6 was established for 2 (found m/z 375.1820, calcd 
375.1813 for [M – H]–, Δ 0.7 ppm). The 1H NMR spectrum of 
2 showed some similarities with the spectrum of the  
ganomycins, e.g. the presence of the hydroquinone as well as 
methyl groups, but it also showed marked differences (NMR 
data see Table 1). Three methyl group protons were observable.
In contrast to the ganomycins A and B, only one methine  
proton resonance was observable in the range of 5.0 to 6.0 
ppm, but two additional signals were observed at δ 7.35 ppm 
(H-2) and δ 6.23 ppm (H-1), according to the COSY spectrum 
corresponding to directly adjacent protons. The low field  
resonances indicated strong electron drawing mesomeric 
and/or inductive influences on these protons. Based on COSY 
(no additional protons in this spin system), HSQC (H-1 is  
attached to an alcoholic carbon at δ 80.0 ppm, H-2 is attached 
to a carbon at δ 151.2 ppm, indicating a double bond under 
mesomeric influence of a carbonyl group) and HMBC data 
(correlations between H-1 and a hydrogen-free sp2 carbon at δ 
133.3 ppm and between H-2 and a carbonyl carbon at δ 177.0 
ppm as well as a sp3 carbon triplet at δ 27.1 ppm), these non-
aromatic protons could be assigned to an unsaturated isoprene 
lactone, and HMBC correlations from the proton H-4 extended 
into yet another attached unmodified isoprene unit. Indeed, the 
proton and carbon shifts of the postulated hydroquinone-
isoprenelactone fragment in 2 agree very well with the NMR 
data of the corresponding fragment in ganomycin I, previously 
described from Ganoderma colossum.13 However, two  
additional carbon signals at δ 74.0 ppm and 79.2 ppm,  
according to HMBC correlations belonging to two vicinal 
carbons, indicated the presence of two carbon-oxygen bonds 
not present in ganomycin I. These observed shifts correspond 
well to those of a dihydroxy isoprene moiety observed in  
other natural products.14–16 The identified hydroquinone-
isoprenelactone and dihydroxy isoprene moieties could be 
connected based on several HMBC correlations as indicated in 
Table 1 to give the planar structure of 2. The absolute  
configuration at C-1 was established using the circular dichroic
method described for the determination of the absolute  
configuration of 5-substituted 2-(5H)-furanones, where it is 
known that the sign of the Cotton effect due to the n-π* and π-
π* transitions is directly correlated with the absolute  
configuration of the stereogenic center at the γ-carbon of the 
butenolide moiety.17,18 The CD spectrum of 2 displayed a  
negative Cotton effect at 213 nm and a positive Cotton effect 
at 233 nm, indicating “M helicity” for the present lactone.17 
Therefore, the absolute configuration at C-1 could be assigned 
as R. The same configuration at C-1 has also been observed for 
ganomycin I.13 Stereochemistry at C-10 could not be  
determined. 
Taking into account all analytical data, compound 2 could 
Table 1. 1H and 13C NMR data for ganomycin K (2) in methanol-d4 (600 MHz 1H NMR frequency) 
position δC δH (J in Hz) HMBCa NOESY 
1' 149.1, C    
2' 123.7, C    
3' 113.5, CH 6.46, d, (2.8) 1', 5', 1  
4' 151.6, C    
5' 117.42, CH 6.61, dd, (8.7, 2.9) 1', 3' 6' 
6' 117.38, CH 6.68, d, (8.6) 2', 4', 1 5' 
1 80.0, CH 6.23, s 1', 2', 3', 2, 3 2 
2 151.2, CH 7.35, s 1, 3, 4, 15 1, 4, 5 
3 133.3, C    
4 27.1, CH2 2.35, m 2, 3, 5, 6, 15 2, 6 
5 26.3, CH2 2.31, m 3, 6, 7 2, 6, 8, 14 
6 124.3, CH 5.20, br. s 4, 5, 8, 14 4, 5, 8 
7 138.0, C    
8 38.0, CH2 2.00, m 6, 7, 9, 10, 14 5, 6, 9, 10, 14 
9 30.9, CH2 1.31, m 7, 8, 10, 11, 12 8, 10, 13, 14 
10 79.2, CH 3.22, ddd, (10.6, 3.5, 1.7) 8, 9, 11, 12, 13 8, 9, 12, 13, 14 
11 74.0, C    
12 25.1, CH3 1.11, s 9, 10, 13 9, 10, 14 
13 25.8, CH3 1.14, d, (3.4) 9, 10, 12 9, 10, 14 
14 16.4, CH3 1.60, s 6, 7, 8 5, 8, 9, 10, 12, 13 
15 177.0, C    
aHMBC correlations are stated from proton to the indicated carbon. 
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be identified as (5S)-3-[(E)-7,8-dihydroxy-4,8-dimethylnon-3-
enyl]-5-(2,5-dihydroxyphenyl)-furan-2(5H)-one. It was named 
ganomycin K. 
In contrast to the positive control ampicillin and to 
ganomycin B, 1 did not show any antibacterial activity against 
the test strains at 100 µg/disc in the agar diffusion assay; at the 
same concentration, compound 2 exhibited moderate activity 
only against St. aureus, North German Epidemic Strain, and 
was inactive against the other strains tested. The assay results 
indicate that the free carboxylic acid group present in the 




General Experimental Procedures. NMR spectra were 
recorded in CDCl3 at 500 MHz (1H NMR frequency; 1) and 
methanol-d4 at 600 MHz (1H NMR frequency; 2) at  
ambient temperature using a Bruker Avance-II 600. Spectra 
were referenced indirectly to tetramethylsilane via the residual 
signals of the deuterated solvent. ITTOF MS data have been 
acquired using an HPLC coupled to an ITTOF mass  
spectrometer (Shimadzu Europe GmbH, Duisburg, Germany) 
with electrospray ionization in negative mode, and were  
evaluated using the vendor’s software LCMSSolution version 
3.60.361 with Formula Predictor version 1.13. Precursor ions 
corresponding to [M – H]– were isolated in the ion trap and  
separated in the TOF analyzer. For the calculation of sum  
formulae, the monoisotopic mass averaged from at least three 
scans has been used. GC-MS data were obtained using an  
Agilent 6890N Network GC system including a 5973 mass 
selective detector and a 7683 injector system. GC and MS data 
were recorded using version SWG1701CA C.00.00 21-Dec-
1999 of the Chemstation software by Agilent technologies. CD 
spectra were recorded on a Jasco 710 spectropolarimeter at 
room temperature in the range of 200–400 nm (step resolution 
1 nm, speed 50 nm/min, response 2 sec, bandwidth 1 nm,  
sensitivity 10 mdeg, accumulation 3). IR spectra were  
recorded on a Thermo Electron Corp. Nicolet IR 200 FT-IR 
(ATR mode, 64 scans). Column chromatography was carried 
out on Sephadex LH-20 (Amersham Biosciences, Uppsala, 
Sweden). Fractions were monitored by TLC (silica gel 60 254 
nm) using toluene-ethyl acetate-acetic acid (7:3:0.1) as mobile 
phase (1 black, 2 yellow after spraying with anisaldehyde 
sulphuric acid reagent). Analytical HPLC was performed on a 
DIONEX HPLC system using an ASI-100 autosampler and the 
UVD-340S diode array detector (200–595 nm). The system 
was running on a Gynkotek HP480 pump. An endcapped RP18 
column (125  4.6 mm, 5 µm) was used at a flow rate of 1.5 
mL/min. A solvent system consisting of methanol (eluent A) 
and 0.1% (m/m) phosphoric acid (eluent B), starting from an 
initial ratio of 10% A and 90% B and reaching 100% A within 
13.0 min, was used. Semi-preparative HPLC was performed 
on a YMC-Pack ODS-AQ column (250  20 mm, 10 µm) 
using a DIONEX HPLC system including a ASI-100 
autosampler, a DIONEX P580 pump, a Gynkotek UVD-160 
variable wavelength detector, and a Isco Foxy 200 fraction 
collector. All HPLC runs were recorded using the Chromeleon 
HPLC data system using version 6.30 SP1 built 587. All 
chemicals were used as received, solvents were distilled prior 
to use. 
 
Fungal Material. Mature fruiting bodies of G. pfeifferi 
were collected on the grounds of Castle Ludwigsburg in the 
vicinity of Greifswald (Germany) in September 2002. They 
were taken from the same stump of Fagus sp. from which the 
fruiting bodies were collected for earlier studies of our group. 
They were kindly identified by Prof. Dr. H. Kreisel,  
Department of Biology, Ernst-Moritz-Arndt-Universität, 
Greifswald, Germany. A voucher specimen (herbarium  
accession number PI-28) is deposited at the Department of 
Pharmaceutical Biology, Ernst-Moritz-Arndt-Universität. 
 
Extraction and Isolation. Air-dried and powdered fruiting 
bodies of G. pfeifferi (288 g) were extracted with CH2Cl2 in a 
soxhlet apparatus for 18 h to give a crude extract (8.5 g). The 
crude extract was rinsed with 450 mL of n-hexane-CH2Cl2 (2:7) 
on a Sephadex LH-20 column (open column, 3 × 35 cm, water 
cooled, flow 24 mL/h). The fraction not eluting was washed 
off with MeOH (F1-2, 2.9 g) and further fractionated into 100 
fractions on a Sephadex LH-20 column (open column, 2 × 35 
cm, water cooled, flow 20 mL/h) with 400 mL of MeOH-H2O 
(2:1). Every second fraction was analysed by HPLC as  
described above, and fractions containing 1 or 2 were  
combined and dried. Further purification by semi-preparative 
HPLC afforded 47 mg of compound 1 and 20 mg of  
compound 2. Farnesylhydroquinone (1) was purified using a 
flow rate of 18 mL/min and a solvent system consisting of 
methanol (eluent A) and water (eluent B), starting from an 
initial ratio of 20% B for 2.5 min and then reaching 0% B 
within 8.5 min. For the isolation of ganomycin K (2), a  
gradient from 65% B reaching 45% B in 5 min, holding for 5 
min and then reaching 0% B in 5 min with a flow rate of 16 
mL/min was used. 
 
Synthesis of Farnesylhydroquinone (1). 1 has been  
synthesized as described in the literature.19 Hydroquinone (437 
mg) and farnesol (435 mg) were dissolved in 5 mL of  
anhydrous diethyl ether under argon. After addition of 0.4 mL 
of BF3 etherate, the solution was stirred at room temperature 
for three hours. After addition of water, the product was  
extracted using diethyl ether and isolated using silica column 
chromatography (unoptimized yield: 23%). 
 
Ganomycin K (2). (5S)-3-[(E)-7,8-dihydroxy-4,8-
dimethylnon-3-enyl]-5-(2,5-dihydroxyphenyl)-furan-2(5H)-one;
yellow oil; TLC toluene-EtOAc-CH3COOH (7:3:0.1) Rf 0.26 
(yellow after spraying with anisaldehyde-H2SO4 reagent); UV 
(MeOH) λmax (log ε) 203 (4.36), 298 (3.57) nm; CD (MeOH) ∆ε213 – 1.38 (π-π*), ∆ε233 + 7.13 (n-π*); IR νmax 3282, 2935, 
1736, 1645, 1585, 1504, 1454, 1375, 1280, 1200, 1159, 1080, 
1054, 1024, 981, 814, 791, 740, and 714 cm–1; 1H and 13C 
NMR (methanol-d4, 600 MHz) see Table 1; negative ion 
HREIMS m/z 375.1820 (calcd for C21H27O6 [M – H]–, 
375.1813, Δ 0.7 ppm). Complete NMR and MS raw data of 
ganomycin K (2) are available free of charge for download at 
http://dx.doi.org/10.6084/m9.figshare.686085. 
 
Antimicrobial Test System. The antimicrobial tests were 
performed with Gram-positive bacteria (S. aureus ATCC 6538, 
S. aureus North German Epidemic Strain, S. aureus 34289, S. 
aureus 36881, S. aureus 38418, S. aureus 520, S. aureus 315, 
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S. epidermidis 847, S. epidermidis 125, S. haemolyticus 535) 
by the agar diffusion method. Ampicillin (SIGMA) and 
coenzyme Q10 (SIGMA) were used as controls. Substance-
containing paper disks (6 mm diameter) were deposited on the 
surface of agar plates (nutrition agar, SIFIN, Berlin) seeded 
with overnight cultures of the test microorganisms. The plates 
were incubated for 18 h at 37 °C. After incubation the 
inhibition zones were measured and recorded as the diameter 
of the zone. 
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Supplementary material is available in the online version of 
this article at http://dx.doi.org/10.1007/s13659-013-0036-5 
and is accessible for authorized users. 
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